Dorsey & Whitney Trust’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$791K Sell
3,331
-110
-3% -$22.9K 0.04% 355
2026
Q1
$727K Buy
3,441
+96
+3% +$20.7K 0.04% 352
2025
Q4
$687K Buy
3,345
+248
+8% +$46.7K 0.04% 362
2025
Q3
$486K Sell
3,097
-5
-0.2% -$772 0.03% 433
2025
Q2
$521K Buy
3,102
+107
+4% +$15.9K 0.03% 410
2025
Q1
$413K Sell
2,995
-133
-4% -$17K 0.02% 443
2024
Q4
$370K Buy
3,128
+155
+5% +$18.1K 0.02% 460
2024
Q3
$329K Buy
2,973
+548
+23% +$57.3K 0.02% 491
2024
Q2
$238K Sell
2,425
-63
-3% -$6.42K 0.02% 543
2024
Q1
$278K Sell
2,488
-444
-15% -$47.9K 0.02% 500
2023
Q4
$296K Sell
2,932
-131
-4% -$13K 0.02% 457
2023
Q3
$266K Sell
3,063
-103
-3% -$9.31K 0.02% 459
2023
Q2
$299K Buy
+3,166
New +$267K 0.02% 441

Other funds holding CAH

Dorsey & Whitney Trust's CAH Position: Q2 2026 in Review

Dorsey & Whitney Trust reduced its Cardinal Health (CAH) stake by 3.2% in Q2 2026, selling an estimated $22.9K and leaving 3,331 shares worth $791K. The position accounts for 0.04% of the portfolio, ranked #355.

Dorsey & Whitney Trust first reported a position in CAH in Q2 2023 and has held it in 13 quarters since. 1,500 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Dorsey & Whitney Trust held 3,331 shares of Cardinal Health worth $791K as of Q2 2026.
  • Dorsey & Whitney Trust sold 110 Cardinal Health shares in Q2 2026, an estimated $22.9K.
  • Cardinal Health made up 0.04% of Dorsey & Whitney Trust's portfolio in Q2 2026, its #355 holding.
  • Dorsey & Whitney Trust first reported a position in Cardinal Health in Q2 2023 and has held it in 13 quarters since.
  • 1,500 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Dorsey & Whitney Trust's 13F filing for Q2 2026, filed 14 Aug 2026.